This resolution expresses support for designating November as Complex Regional Pain Syndrome and Reflex Sympathetic Dystrophy Syndrome Awareness Month . It highlights CRPS/RSD as a rare, neuro-inflammatory syndrome characterized by intense chronic pain, swelling, and functional impairment, which can lead to disability if not diagnosed and treated early. The resolution notes that CRPS/RSD is an obscure and poorly understood condition with no single diagnostic test or cure, and currently lacks any FDA-approved treatments. Patients face significant challenges in obtaining diagnosis, accessing specialized care, and finding effective treatment options, underscoring a critical need for research and development. By supporting this awareness month, the House of Representatives aims to improve public understanding, encourage accurate and early diagnosis, and advance critical research. It also seeks to foster the development of new treatments, diagnostics, and cures, while identifying efficient regulatory pathways for drug development for ultrarare diseases like CRPS/RSD.